[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369336-105":59,"doc-detail-369336-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibition-of-human-hpv-hybrid-ecdna-enhancers-reduces-oncogene-expression-and-tumor-growth-in-oropharyngeal-cancer","Inhibition of human-HPV hybrid ecDNA enhancers reduces oncogene expression and tumor growth in oropharyngeal cancer","","Inhibition of human-HPV hybrid ecDNA enhancers is investigated in HPV-mediated oropharyngeal cancer using HPVOPC cell lines and patient-derived xenografts (PDX). The study characterizes hybrid ecDNA epigenetic status and identifies HPV oncogenes E6/E7 as being flanked by previously unrecognized somatic DNA enhancers and HPV L1 enhancers with strong cis-interactions. Disrupting these enhancers via CRISPR interference or targeting hybrid ecDNA with a BET inhibitor reduces E6/E7 expression and significantly inhibits in vitro and in vivo tumor growth in ecDNA(+) models, highlighting therapeutic vulnerabilities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibition-of-human-hpv-hybrid-ecdna-enhancers-reduces-oncogene-expression-and-tumor-growth-in-oropharyngeal-cancer/369336/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibition-of-human-hpv-hybrid-ecdna-enhancers-reduces-oncogene-expression-and-tumor-growth-in-oropharyngeal-cancer/369336.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is hybrid ecDNA in HPV-mediated oropharyngeal cancer?","Question",{"text":112,"@type":113},"Hybrid ecDNA refers to extrachromosomal circular DNA that incorporates viral genomes, here within HPV-driven oropharyngeal cancer contexts. The paper focuses on how these structures influence oncogene regulation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study characterize the epigenetic and interaction features of hybrid ecDNA?",{"text":117,"@type":113},"It examined hybrid ecDNA using HPVOPC cell lines and patient-derived tumor xenografts, identifying active enhancers around HPV oncogenes E6/E7 and using HiC-seq to detect strong cis-interactions between the enhancers and E6/E7.",{"name":119,"@type":110,"acceptedAnswer":120},"Which interventions were tested, and what were the outcomes?",{"text":121,"@type":113},"The researchers used CRISPR interference to inactivate the identified enhancers and used bromodomain and extra-terminal (BET) inhibitors to target hybrid ecDNA structures. Both approaches reduced E6/E7 expression and significantly inhibited growth in ecDNA(+) cell lines and PDX tumors, with effects not observed in ecDNA(−) models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369336,1790546240,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article [https://doi.org/10.1038/s41467-025-57447-9](https://doi.org/10.1038/s41467-025-57447-9)  \nInhibition of human-HPV hybrid ecDNA enhancers reduces oncogene expression and tumor growth in oropharyngeal cancer  \nReceived: 22 July 2024  \n\n| Accepted: 22 February 2025 |\n| --- |\n| |\n| Check for updates |\n\nTakuya Nakagawa 1,2,3 , Jens Luebeck 4, Kaiyuan Zhu4, Joshua T. Lange5, Roman Sasik 6, Chad Phillips1, Sayed Sadat1, Sara Javadzadeh4, Qian Yang7, Abdula Monther1, Santiago Fassardi1, Allen Wang 7, Kersi Pestonjamasp8, Brin Rosenthal6, Kathleen M. Fisch 6, Paul Mischel 5, Vineet Bafna 4 & Joseph A. Califano 1,9   \nExtrachromosomal circular DNA (ecDNA) has been found in most types of human cancers, and ecDNA incorporating viral genomes has recently been described, speciﬁcally in human papillomavirus (HPV)-mediated oropharyngeal cancer (OPC). However, the molecular mechanisms of human-viral hybrid ecDNA (hybrid ecDNA) for carcinogenesis remains elusive. We characterize the epigenetic status of hybrid ecDNA using HPVOPC cell lines and patient-derived tumor xenografts, identifying HPV oncogenes E6/E7 in hybrid ecDNA are ﬂanked by previously unrecognized somatic DNA enhancers and HPV L1 enhancers, with strong cis-interactions. Targeting of these enhancers by clustered regularly interspaced short palindromic repeats interference or hybrid ecDNA by bromodomain and extra-terminal inhibitor reduces E6/E7 expression, and signiﬁcantly inhibites in vitro and/or in vivo growth only in ecDNA(+) models. HPV DNA in hybrid ecDNA structures are associated with previously unrecognized somatic and HPV enhancers in hybrid ecDNA that drive HPV ongogene expression and carcinogenesis, and can be targeted with ecDNA disrupting therapeutics.  \nExtrachromosomal circular DNA (ecDNA) represents a frequent driver of focal oncogene ampliﬁcation during carcinogenesis, and the subsequent high expression of the genes carried on ecDNA1–3. This phenomenon is facilitated by the circular structure and open-chromatin conﬁguration of ecDNA4, allowing transcriptional factors to easily access ecDNA. The unique spatial reorganization of ecDNA is thought to create additional topological domains, providing opportunities for previously unrecognized interactions between oncogenes and distant  \nregulatory elements, and ecDNA mediated cis-interactions between enhancers and oncogenes (“enhancer hijacking”). Oncogenes residing on chromosomal DNA in the human genome may also be activated using so-called “mobile enhancers” from free-ﬂoating ecDNA5. Furthermore, ecDNA segments in close proximity may also interact through “ecDNA hubs”6,7.  \nRecent studies have shown that in Human papillomavirus (HPV) -mediated cancers, human DNA and viral genomes can form circular  \n1Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA. 2Department of Otorhinolaryngology, Head and Neck Surgery, Chiba University, Graduate School of Medicine, Chiba, Japan. 3Health and Disease Omics Center, Chiba University, Chiba, Japan. 4Department of Computer Science and Engineering, UC San Diego, La Jolla, CA, USA. 5Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. 6Center for Computational Biology and Bioinformatics, University of California, San Diego, La Jolla, CA, USA. 7Department of Cellular and Molecular Medicine, Center for Epigenomics, University of California, San Diego, La Jolla, CA, USA. 8Cancer Center Microscopy Core, University of California, San Diego, La Jolla, CA, USA. 9Department of Otolaryngology—Head and Neck Surgery and Gleiberman Head and Neck Cancer Center, University of California, San Diego, La Jolla, CA, USA. e-mail: [tanakagawa@health.ucsd.edu](tanakagawa@health.ucsd.edu); [tnakagawa@chiba-u.jp](tnakagawa@chiba-u.jp); [jcalifano@health.ucsd.edu](jcalifano@health.ucsd.edu)  \nhuman–viral hybrid ecDNA (hybrid ecDNA). HPV is an approximately 8kbp circular double-stranded DNA virus and includes oncogenes called E6 and E78,9. HPV-med","cbCaiiLnLgrBqqAk","https://ap.wps.com/l/cbCaiiLnLgrBqqAk","pdf",3248591,13,"English","# Results\n## Identification of hybrid ecDNA in HPVOPC cell lines and PDX tumors","[{\"question\":\"What is hybrid ecDNA in HPV-mediated oropharyngeal cancer?\",\"answer\":\"Hybrid ecDNA refers to extrachromosomal circular DNA that incorporates viral genomes, here within HPV-driven oropharyngeal cancer contexts. The paper focuses on how these structures influence oncogene regulation.\"},{\"question\":\"How did the study characterize the epigenetic and interaction features of hybrid ecDNA?\",\"answer\":\"It examined hybrid ecDNA using HPVOPC cell lines and patient-derived tumor xenografts, identifying active enhancers around HPV oncogenes E6/E7 and using HiC-seq to detect strong cis-interactions between the enhancers and E6/E7.\"},{\"question\":\"Which interventions were tested, and what were the outcomes?\",\"answer\":\"The researchers used CRISPR interference to inactivate the identified enhancers and used bromodomain and extra-terminal (BET) inhibitors to target hybrid ecDNA structures. Both approaches reduced E6/E7 expression and significantly inhibited growth in ecDNA(+) cell lines and PDX tumors, with effects not observed in ecDNA(−) models.\"}]","Inhibition of human-HPV hybrid ecDNA enhancers reduces oncogene expression and tumor growth in oropharyngeal cancer | PDF",1790182104,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/402f3f73f51e945e1f031fc999380a81.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c551d7353c1bf68c8aa16dd5cbe08e4.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df2fa81ca31b0136ccbf061274c45760.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54013a155ee26cc5b0872f1f471d9d5c.webp",980,1301]